esmolol has been researched along with Shock, Cardiogenic in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Aljundi, A; Alyafei, S; Kasem, M; Mahfouz, A; Omar, AS; Rahhal, A | 1 |
| Biesenbach, E; Caglayan, E; Dahlem, KM; Er, F; Eran-Ergöknil, A; Erdmann, E; Gassanov, N; Hellmich, M; Herrfurth, T; Kuhr, K; Le, MT; Nia, AM; Taghiyev, Z; Vanezi, M; Waltenberger, J; Yüksel, D | 1 |
| Makris, D; Papanikolaou, J; Spathoulas, K; Tsolaki, V; Zakynthinos, E | 1 |
| Purnell, R; Taylor, JS; Yousef, ZR | 1 |
| Baldassarri, R; Guarracino, F; Landoni, G; Nobile, L; Stefani, M | 1 |
| Alhashemi, JA | 1 |
| Imagawa, H; Kadoba, K; Masai, T; Matsuda, H; Sawa, Y; Takahashi, T; Taniguchi, K | 1 |
1 review(s) available for esmolol and Shock, Cardiogenic
| Article | Year |
|---|---|
Successful Use of Intravenous B-blocker Therapy in Cardiogenic Shock Supported With Venoarterial Extracorporeal Membrane Oxygenation: A Case Series.
Topics: Extracorporeal Membrane Oxygenation; Humans; Lactates; Myocardial Infarction; Propanolamines; Shock, Cardiogenic | 2022 |
1 trial(s) available for esmolol and Shock, Cardiogenic
| Article | Year |
|---|---|
Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Topics: Adrenergic beta-1 Receptor Antagonists; Biomarkers; Creatine Kinase; Female; Germany; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Percutaneous Coronary Intervention; Prognosis; Propanolamines; Prospective Studies; Shock, Cardiogenic; Single-Blind Method; Tachycardia, Ventricular; Troponin T | 2016 |
5 other study(ies) available for esmolol and Shock, Cardiogenic
| Article | Year |
|---|---|
Post-partum hemorrhage complicated by reverse-Takotsubo cardiogenic shock; a novel therapeutic approach.
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Cesarean Section; Echocardiography; Female; Humans; Postoperative Complications; Postpartum Hemorrhage; Postpartum Period; Pregnancy; Prognosis; Propanolamines; Shock, Cardiogenic; Takotsubo Cardiomyopathy; Ventricular Function, Left | 2017 |
Acquired left ventricular outflow tract obstruction and cardiogenic shock treated with beta-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Electrocardiography; Female; Humans; Propanolamines; Shock, Cardiogenic; Ventricular Outflow Obstruction | 2009 |
Concomitant levosimendan and esmolol infusion in ischaemic cardiogenic shock.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan | 2010 |
Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Drug Therapy, Combination; Humans; Hydrazones; Male; Middle Aged; Myocardial Infarction; Propanolamines; Pyridazines; Shock, Cardiogenic; Simendan | 2005 |
Repair of postinfarction ventricular septal defect on a beating heart.
Topics: Adrenergic beta-Antagonists; Aged; Body Temperature; Cardiopulmonary Bypass; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Propanolamines; Shock, Cardiogenic; Ventricular Septal Rupture | 1996 |